10-K Decoder · All companies

Collegium Pharmaceutical, Inc.

COLL · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$781M$631M+23.6%
Operating income$180M$170M+5.7%
Net income$62.9M$69.2M−9.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026

$Q3 2026Year earlierChange
Revenue$216M$209M+3.3%
Operating income$28.7M$62.1M−53.8%
Net income$21.8M$31.5M−30.8%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Collegium's revenue in FY2025?
$781M in FY2025 (Fiscal year ended Dec 31, 2025), +23.6% vs $631M a year earlier, per its 10-K filed Feb 2026.
Was Collegium profitable in FY2025?
Yes: net income was $62.9M and operating income $180M in FY2025.
What was Collegium's revenue in Q3 2026?
$216M (+3.3% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.